treatment
Treatment for Ovarian Cancer Patients After PARP Inhibitor MaintenanceBy Catlin NalleyA recent study found that ovarian cancer patients responded to both platinum-based and non-platinum-based chemotherapy following progression of disease on PARP inhibitors. The data, which was presented at the ASCO 2021 Virtual Annual Meeting, also showed that time to progression on subsequent chemotherapy…